2024-02-122025-02-282025-02-28false15485506Wellbeing Clinic Essex Ltd2025-05-1296040falseiso4217:GBPxbrli:pure154855062024-02-11154855062025-02-28154855062024-02-122025-02-28154855062024-02-10154855062024-02-11154855062024-02-112024-02-1115485506bus:SmallEntities2024-02-122025-02-2815485506bus:AuditExempt-NoAccountantsReport2024-02-122025-02-2815485506bus:FullAccounts2024-02-122025-02-2815485506bus:PrivateLimitedCompanyLtd2024-02-122025-02-2815485506core:WithinOneYear2025-02-2815485506core:AfterOneYear2025-02-2815485506core:WithinOneYear2024-02-1115485506core:AfterOneYear2024-02-1115485506core:ShareCapital2025-02-2815485506core:SharePremium2025-02-2815485506core:RevaluationReserve2025-02-2815485506core:OtherReservesSubtotal2025-02-2815485506core:RetainedEarningsAccumulatedLosses2025-02-2815485506core:ShareCapital2024-02-1115485506core:SharePremium2024-02-1115485506core:RevaluationReserve2024-02-1115485506core:OtherReservesSubtotal2024-02-1115485506core:RetainedEarningsAccumulatedLosses2024-02-1115485506core:LandBuildings2025-02-2815485506core:PlantMachinery2025-02-2815485506core:Vehicles2025-02-2815485506core:FurnitureFittings2025-02-2815485506core:OfficeEquipment2025-02-2815485506core:NetGoodwill2025-02-2815485506core:IntangibleAssetsOtherThanGoodwill2025-02-2815485506core:ListedExchangeTraded2025-02-2815485506core:UnlistedNon-exchangeTraded2025-02-2815485506core:LandBuildings2024-02-1115485506core:PlantMachinery2024-02-1115485506core:Vehicles2024-02-1115485506core:FurnitureFittings2024-02-1115485506core:OfficeEquipment2024-02-1115485506core:NetGoodwill2024-02-1115485506core:IntangibleAssetsOtherThanGoodwill2024-02-1115485506core:ListedExchangeTraded2024-02-1115485506core:UnlistedNon-exchangeTraded2024-02-1115485506core:LandBuildings2024-02-122025-02-2815485506core:PlantMachinery2024-02-122025-02-2815485506core:Vehicles2024-02-122025-02-2815485506core:FurnitureFittings2024-02-122025-02-2815485506core:OfficeEquipment2024-02-122025-02-2815485506core:NetGoodwill2024-02-122025-02-2815485506core:IntangibleAssetsOtherThanGoodwill2024-02-122025-02-2815485506core:ListedExchangeTraded2024-02-122025-02-2815485506core:UnlistedNon-exchangeTraded2024-02-122025-02-2815485506core:MoreThanFiveYears2024-02-122025-02-2815485506core:Non-currentFinancialInstruments2025-02-2815485506core:Non-currentFinancialInstruments2024-02-1115485506dpl:CostSales2024-02-122025-02-2815485506dpl:DistributionCosts2024-02-122025-02-2815485506core:LandBuildings2024-02-122025-02-2815485506core:PlantMachinery2024-02-122025-02-2815485506core:Vehicles2024-02-122025-02-2815485506core:FurnitureFittings2024-02-122025-02-2815485506core:OfficeEquipment2024-02-122025-02-2815485506dpl:AdministrativeExpenses2024-02-122025-02-2815485506core:NetGoodwill2024-02-122025-02-2815485506core:IntangibleAssetsOtherThanGoodwill2024-02-122025-02-2815485506dpl:GroupUndertakings2024-02-122025-02-2815485506dpl:ParticipatingInterests2024-02-122025-02-2815485506dpl:GroupUndertakingscore:ListedExchangeTraded2024-02-122025-02-2815485506core:ListedExchangeTraded2024-02-122025-02-2815485506dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-02-122025-02-2815485506core:UnlistedNon-exchangeTraded2024-02-122025-02-2815485506dpl:CostSales2024-02-112024-02-1115485506dpl:DistributionCosts2024-02-112024-02-1115485506core:LandBuildings2024-02-112024-02-1115485506core:PlantMachinery2024-02-112024-02-1115485506core:Vehicles2024-02-112024-02-1115485506core:FurnitureFittings2024-02-112024-02-1115485506core:OfficeEquipment2024-02-112024-02-1115485506dpl:AdministrativeExpenses2024-02-112024-02-1115485506core:NetGoodwill2024-02-112024-02-1115485506core:IntangibleAssetsOtherThanGoodwill2024-02-112024-02-1115485506dpl:GroupUndertakings2024-02-112024-02-1115485506dpl:ParticipatingInterests2024-02-112024-02-1115485506dpl:GroupUndertakingscore:ListedExchangeTraded2024-02-112024-02-1115485506core:ListedExchangeTraded2024-02-112024-02-1115485506dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-02-112024-02-1115485506core:UnlistedNon-exchangeTraded2024-02-112024-02-1115485506core:NetGoodwill2025-02-2815485506core:IntangibleAssetsOtherThanGoodwill2025-02-2815485506core:LandBuildings2025-02-2815485506core:PlantMachinery2025-02-2815485506core:Vehicles2025-02-2815485506core:FurnitureFittings2025-02-2815485506core:OfficeEquipment2025-02-2815485506core:AfterOneYear2025-02-2815485506core:WithinOneYear2025-02-2815485506core:ListedExchangeTraded2025-02-2815485506core:UnlistedNon-exchangeTraded2025-02-2815485506core:ShareCapital2025-02-2815485506core:SharePremium2025-02-2815485506core:RevaluationReserve2025-02-2815485506core:OtherReservesSubtotal2025-02-2815485506core:RetainedEarningsAccumulatedLosses2025-02-2815485506core:NetGoodwill2024-02-1115485506core:IntangibleAssetsOtherThanGoodwill2024-02-1115485506core:LandBuildings2024-02-1115485506core:PlantMachinery2024-02-1115485506core:Vehicles2024-02-1115485506core:FurnitureFittings2024-02-1115485506core:OfficeEquipment2024-02-1115485506core:AfterOneYear2024-02-1115485506core:WithinOneYear2024-02-1115485506core:ListedExchangeTraded2024-02-1115485506core:UnlistedNon-exchangeTraded2024-02-1115485506core:ShareCapital2024-02-1115485506core:SharePremium2024-02-1115485506core:RevaluationReserve2024-02-1115485506core:OtherReservesSubtotal2024-02-1115485506core:RetainedEarningsAccumulatedLosses2024-02-1115485506core:NetGoodwill2024-02-1015485506core:IntangibleAssetsOtherThanGoodwill2024-02-1015485506core:LandBuildings2024-02-1015485506core:PlantMachinery2024-02-1015485506core:Vehicles2024-02-1015485506core:FurnitureFittings2024-02-1015485506core:OfficeEquipment2024-02-1015485506core:AfterOneYear2024-02-1015485506core:WithinOneYear2024-02-1015485506core:ListedExchangeTraded2024-02-1015485506core:UnlistedNon-exchangeTraded2024-02-1015485506core:ShareCapital2024-02-1015485506core:SharePremium2024-02-1015485506core:RevaluationReserve2024-02-1015485506core:OtherReservesSubtotal2024-02-1015485506core:RetainedEarningsAccumulatedLosses2024-02-1015485506core:AfterOneYear2024-02-122025-02-2815485506core:WithinOneYear2024-02-122025-02-2815485506core:Non-currentFinancialInstrumentscore:CostValuation2024-02-122025-02-2815485506core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-122025-02-2815485506core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-122025-02-2815485506core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-122025-02-2815485506core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-122025-02-2815485506core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-122025-02-2815485506core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-122025-02-2815485506core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-122025-02-2815485506core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-122025-02-2815485506core:Non-currentFinancialInstrumentscore:CostValuation2025-02-2815485506core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-02-2815485506core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-02-2815485506core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-02-2815485506core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-02-2815485506core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-02-2815485506core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-02-2815485506core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-02-2815485506core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-02-2815485506core:Non-currentFinancialInstrumentscore:CostValuation2024-02-1115485506core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-1115485506core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-1115485506core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-1115485506core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-1115485506core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-1115485506core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-1115485506core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-1115485506core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-1115485506bus:Director12024-02-122025-02-2815485506bus:Director22024-02-122025-02-28

Wellbeing Clinic Essex Ltd

Registered Number
15485506
(England and Wales)

Unaudited Financial Statements for the Period ended
28 February 2025

Wellbeing Clinic Essex Ltd
Company Information
for the period from 12 February 2024 to 28 February 2025

Directors

Claire Barker
Susan Porter

Registered Address

132 North Station Road
Colchester
CO1 1UZ

Registered Number

15485506 (England and Wales)
Wellbeing Clinic Essex Ltd
Statement of Financial Position
28 February 2025

Notes

2025

£

£

Fixed assets
Tangible assets328,996
28,996
Current assets
Debtors410,998
Cash at bank and on hand10,258
21,256
Creditors amounts falling due within one year5(1,382)
Net current assets (liabilities)19,874
Total assets less current liabilities48,870
Creditors amounts falling due after one year6(77,420)
Net assets(28,550)
Capital and reserves
Called up share capital100
Profit and loss account(28,650)
Shareholders' funds(28,550)
The financial statements were approved and authorised for issue by the Board of Directors on 12 May 2025, and are signed on its behalf by:
Claire Barker
Director
Susan Porter
Director

Registered Company No. 15485506
Wellbeing Clinic Essex Ltd
Notes to the Financial Statements
for the period ended 28 February 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Straight line (years)
Land and buildings8
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.
2.Average number of employees

2025
Average number of employees during the year6
3.Tangible fixed assets

Land & buildings

Total

££
Cost or valuation
Additions33,13933,139
At 28 February 2533,13933,139
Depreciation and impairment
Charge for year4,1434,143
At 28 February 254,1434,143
Net book value
At 28 February 2528,99628,996
At 11 February 24--
4.Debtors: amounts due within one year

2025

£
Trade debtors / trade receivables198
Prepayments and accrued income10,800
Total10,998
5.Creditors: amounts due within one year

2025

£
Other creditors182
Accrued liabilities and deferred income1,200
Total1,382
6.Creditors: amounts due after one year

2025

£
Other creditors77,420
Total77,420